Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Search
  • Ropeginterferon Alfa-2b: Effic...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups

Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups

Bibliographic Details
Main Authors: Heinz Gisslinger, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva-Kyuchukova, Miklos Egyed, Viktor Rossiev, Petr Dulicek, Arpad Illes, Halyna Pylypenko, Lylia Sivcheva, Jiri Mayer, Vera Yablokova, Kurt Krejcy, Hans C. Hasselbalch, Robert Kralovics, Jean-Jacques Kiladjian, for the PROUD-PV Study Group
Format: Article
Language:English
Published: Wolters Kluwer 2020-12-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/HS9.0000000000000485
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://journals.lww.com/10.1097/HS9.0000000000000485

Similar Items

  • Population Pharmacokinetics of Ropeginterferon Alfa-2b: A Comparison Between Healthy Caucasian and Chinese Subjects
    by: Min Zhu, et al.
    Published: (2021-05-01)
  • Ropeginterferon alfa‐2b in patients with genotype 1 chronic hepatitis C: Pharmacokinetics, safety, and preliminary efficacy
    by: Hsien‐Hong Lin, et al.
    Published: (2021-08-01)
  • Ropeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis C
    by: Shih-Jer Hsu, et al.
    Published: (2021-03-01)
  • THE TRAINING QUALITY IN HIGHER MEDICAL SCHOOLS INFLUENCED BY THE STUDENTS
    by: S. Kyuchukova
    Published: (2020-12-01)
  • Myelomonocytic Skewing In Vitro Discriminates Subgroups of Patients with Myelofibrosis with A Different Phenotype, A Different Mutational Profile and Different Prognosis
    by: Klaus Geissler, et al.
    Published: (2020-08-01)

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...